COST

898.2

+0.63%↑

150.86

+1.74%↑

72.98

+2.43%↑

155.18

-0.41%↓

PEP

146.3

+0.09%↑

COST

898.2

+0.63%↑

150.86

+1.74%↑

72.98

+2.43%↑

155.18

-0.41%↓

PEP

146.3

+0.09%↑

COST

898.2

+0.63%↑

150.86

+1.74%↑

72.98

+2.43%↑

155.18

-0.41%↓

PEP

146.3

+0.09%↑

COST

898.2

+0.63%↑

150.86

+1.74%↑

72.98

+2.43%↑

155.18

-0.41%↓

PEP

146.3

+0.09%↑

COST

898.2

+0.63%↑

150.86

+1.74%↑

72.98

+2.43%↑

155.18

-0.41%↓

PEP

146.3

+0.09%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

7.62 3.25

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.29

Max

7.64

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
EPS	-0.253
Gewinnspanne	-32.116
Angestellte	406

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	19M 260M
Vorheriger Eröffnungskurs	4.37
Vorheriger Schlusskurs	7.62

Nachrichtenstimmung

By Acuity

20%

80%

21 / 148 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Nov. 2025, 22:42 UTC

Market Talk

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21. Nov. 2025, 21:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

21. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. Nov. 2025, 21:47 UTC

Market Talk

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21. Nov. 2025, 21:43 UTC

Market Talk

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21. Nov. 2025, 20:18 UTC

Market Talk

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21. Nov. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21. Nov. 2025, 19:48 UTC

Market Talk

Precious Metals Fall for the Week -- Market Talk

21. Nov. 2025, 19:44 UTC

Ergebnisse

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21. Nov. 2025, 19:37 UTC

Market Talk

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21. Nov. 2025, 19:27 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

21. Nov. 2025, 19:27 UTC

Market Talk

Ergebnisse

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21. Nov. 2025, 19:20 UTC

Market Talk

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21. Nov. 2025, 18:44 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21. Nov. 2025, 18:37 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21. Nov. 2025, 18:34 UTC

Market Talk

Ergebnisse

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21. Nov. 2025, 18:28 UTC

Ergebnisse

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21. Nov. 2025, 18:03 UTC

Market Talk

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21. Nov. 2025, 17:24 UTC

Market Talk

Global Equities Roundup: Market Talk

21. Nov. 2025, 17:24 UTC

Market Talk

Intuit Seen on Path to Increase Growth -- Market Talk

21. Nov. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. Nov. 2025, 17:05 UTC

Market Talk

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

21. Nov. 2025, 16:56 UTC

Market Talk

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

21. Nov. 2025, 16:47 UTC

Market Talk

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

21. Nov. 2025, 16:35 UTC

Akquisitionen, Fusionen, Übernahmen

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

21. Nov. 2025, 16:09 UTC

Ergebnisse

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21. Nov. 2025, 15:59 UTC

Market Talk

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

21. Nov. 2025, 15:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. Nov. 2025, 15:23 UTC

Market Talk

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

21. Nov. 2025, 15:17 UTC

Market Talk

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

21 / 148 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.